Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

PRP improves hair thickness for both genders, but only increases hair density in men.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A patient with a rare hair condition and skin disorder showed hair improvement after treatment.

Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.

Personalized homeopathic treatment may help manage alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Low iron levels may be linked to some types of hair loss in women.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

More research is needed to understand alopecia areata severity.